- Supported exchanges /
- KQ /
- 203400.KQ
Abion Inc. (203400 KQ) stock market data APIs
ABION Inc. operates as a pharmaceutical biotech Company in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a tyrosine kinase inhibitor that is in Phase II clinical trials for treating non-small cell lung cancer, as well as in Phase I clinical trial for breast cancer; ABN501, a human monoclonal antibody that targets claudin 3 for treating solid cancers; ABN201, an antibody cytokine fusion protein to treat solid cancers; and ABN101, a dry powder inhaler as a prophylactic treatment for various respiratory viruses. It is also developing ABN701 for SEBI infectious diseases; and ABN 901, ABN 902, and ABN 903 for infectious diseases related to biological disasters. Abion Inc. was founded in 2007 and is based in Seoul, South Korea.
Abion Inc. Financial Data Overview
| 7750 | |
| 7900 | |
| - | |
| 7900 | |
| 7610 | |
| 4710-13000 | |
| 193 490 M | |
| 25 260 K | |
| 1 325 M | |
| -909.3261 | |
| 1.234 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Abion Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 325 M
- EBITDA -33 652 107 264
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Abion Inc. Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Abion Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
